In Ireland, people living with Type 1 (T1D) and Type 2 Diabetes (T2D) are entitled to a Long-Term Illness (LTI) Scheme. This grants them access free of charge to diabetes medicines and medicines for some associated conditions. Technologies and supplies for blood glucose monitoring and insulin administration are also covered by the LTI Scheme once prescribed by healthcare professionals. The LTI Scheme does not cover people with gestational diabetes.

All types of insulin and other diabetes and cardiovascular medicines are available in the country. Insulin pumps, automated delivery systems and, since December 2023, both intermittently scanned (isCGMs) and real-time continuous glucose monitors (rtCGMs) are reimbursed only for people living with T1D. They are, however, not offered routinely and access to insulin pumps and/or automated delivery systems often involves long waiting lists. There are significant health inequalities as not all clinics provide insulin pumps.

This country profile was developed with the help of Diabetes Ireland.